Eli Lilly opposes the White House's push to codify 'most favored nation' drug pricing, Lilly CEO Dave Ricks said in an interview with CNBC. Lilly is one of more than a dozen pharmaceutical companies ...

Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug. By Rebecca Robbins Eli Lilly reached a deal on Tuesday to buy Centessa ...

Eli Lilly said on Tuesday it would buy Centessa ⁠Pharmaceuticals ‌in ⁠a deal valued at up to $7.8 billion as the U.S. drugmaker looks to diversify beyond its metabolic portfolio and expand into ...

Matthew Herper covers medical innovation — both its promise and its perils. Everything changed with a white envelope. On Dec. 20, 2018, Jacob Van Naarden, the chief operating officer of a biotech ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Eli Lilly’s obesity pill ...

Eli Lilly & Co.’s weight-loss pill won US approval, ratcheting up pressure on Novo Nordisk A/S, which launched an obesity pill earlier this year. Lilly’s once-daily pill, called Foundayo, was approved ...

After an initial AI software licensing deal between Eli Lilly and Insilico Medicine three years ago, the companies are deepening their ties once again with a drug discovery and development ...

Eli Lilly & Co. agreed to buy sleep drug maker Centessa Pharmaceuticals Plc in a deal worth up to $7.8 billion, a sign the weight-loss medication giant is looking to bulk up its treatment pipeline for ...

Eli Lilly LLY2.39%increase; green up pointing triangle has agreed to buy clinical-stage company Centessa Pharmaceuticals CNTA-0.05%decrease; red down pointing triangle for an initial payment of about ...

Eli Lilly LLY2.55%increase; green up pointing triangle signed a drug discovery deal with InSilico that the Hong Kong-listed company says could be valued at as much as $2.75 billion, as global ...

Lilly pill led to 12%-15% reduction in body weight in clinical trials Will be sold as Foundayo and available beginning April 6 FDA fast-tracked approval under Trump-era voucher program The Lilly drug, ...

Eli Lilly received approval for a weight-loss pill. This new product should help strengthen its market position. There are several other reasons to invest in Eli Lilly. On April 1, Eli Lilly announced ...